Registry for patients with Primary Ciliary Dyskinesia in Switzerland
Official title: Swiss Primary Ciliary Dyskinesia Registry
Run by University of Bern · NCT03606200 · Data updated 2026-11-12
This study is creating a registry to collect information about people with Primary Ciliary Dyskinesia in Switzerland to help improve understanding and treatment of the condition.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 800 (estimated) |
| Sponsor | University of Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | January 2013 |
| Main results expected | December 2080 |
| Study ends | December 2080 |
| Registry record updated | November 25, 2025 |
| Trial ID | NCT03606200 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this registry are individuals diagnosed with Primary Ciliary Dyskinesia who can provide informed consent.
✕Probably not a fit
Patients without a diagnosis of Primary Ciliary Dyskinesia will not benefit from participation in this registry.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The Swiss Primary Ciliary Dyskinesia (PCD) Registry is a national initiative that gathers comprehensive data on patients diagnosed with PCD across Switzerland. Established in 2013, it aims to document various aspects of the disease, including diagnosis, symptoms, treatments, and patient outcomes. The registry collects both retrospective data from birth and prospective data at regular intervals, contributing to national and international research efforts. It serves as a platform for monitoring the disease and facilitating clinical and epidemiological studies.
Why it matters
Potential benefit: If successful, this registry could enhance understanding of Primary Ciliary Dyskinesia, leading to improved diagnosis and treatment options for patients.
How similar studies have gone: Other similar registries have shown success in improving patient outcomes and advancing research in related conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients diagnosed with primary ciliary dyskinesia * Signed informed consent or assent Exclusion Criteria: \-
Where it's running
-
University of Bern
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Claudia E Kuehni, Prof — University of Bern
- Study coordinator: Claudia E Kuehni, Prof
- Email: spcdr@hin.ch
- Phone: 0041 316313507
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
International cohort study of patients with Primary Ciliary Dyskinesia
This study looks at how ear, nose, and throat problems affect people with Primary Ciliary Dyskinesia and their lung health, while making sure participants get their usual care.
-
Bronchial hyperresponsiveness in children with primary ciliary dyskinesia
This will see if children with primary ciliary dyskinesia have sensitive airways (bronchial hyperresponsiveness) by using a methacholine breathing challenge and related tests.
-
PALMIRE cohort: phenotyping inflammatory lung diseases to enable personalized care
This project will collect clinical, imaging, and biological data from adults with asthma, COPD, bronchiectasis, cystic fibrosis, primary ciliary dyskinesia, or interstitial lung disease to try to identify disease subtypes and markers that could guide more personalized care.
-
Thermal spa treatment to improve symptoms of primary ciliary dyskinesia
We will try a 3-week thermal spa treatment in adults with primary ciliary dyskinesia to see if it improves ear, nose, and throat symptoms, lowers infection and antibiotic rates, and helps hearing and lung function.
-
Glycine and magnesium plus thiamine for primary ciliary dyskinesia
This trial will test whether daily oral glycine and magnesium with thiamine, alone or combined, can help people aged 5 and older with primary ciliary dyskinesia clear mucus and breathe better.
-
Observational study on Primary Ciliary Dyskinesia
This study looks at people with Primary Ciliary Dyskinesia to see what factors might affect how severe their condition is and to help improve their care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.